Multidimensional quality of life and human–animal bond measures for companion dogs

Schneider, Tamera R.; Lyons, Joseph B.; Tetrick, Mark A.; Accortt, Eynav Elgavish

doi:10.1016/j.jveb.2010.06.002

Cited by 27 publications

(42 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, using these instruments, the comparison of the severity of welfare compromise between one health condition and another is crude if not impractical. Although some generic instruments can be used to assess the welfare of animals with different health conditions [ 15 , 16 ], to the authors’ best knowledge, none has been used for quantifying the degree of impaired welfare caused by different diseases. That said, an attempt to measure the severity of canine inherited diseases was developed by Asher et al and named the Generic Illness Severity Index for Dogs [ 17 ].…”

Section: Introductionmentioning

confidence: 99%

Welfare-Adjusted Life Years (WALY): A novel metric of animal welfare that combines the impacts of impaired welfare and abbreviated lifespan

et al. 2018

View full text Add to dashboard Cite

Currently, separate measures are used to estimate the impact of animal diseases on mortality and animal welfare. This article introduces a novel metric, the Welfare-Adjusted Life Year (WALY), to estimate disease impact by combining welfare compromise and premature death components. Adapting the Disability-Adjusted Life Year approach used in human health audits, we propose WALY as the sum of a) the years lived with impaired welfare due to a particular cause and b) the years of life lost due to the premature death from the same cause. The years lived with impaired welfare are the product of the average duration of each welfare impediment, reflecting the actual condition that compromises animal welfare, the probability of an incident case developing and impaired welfare weights, representing the degree of impaired welfare. The years of life lost are calculated using the standard expected lifespan at the time of premature death. To demonstrate the concept, we estimated WALYs for 10 common canine diseases, namely mitral valve disease, dilated cardiomyopathy, chronic kidney disease, diabetes mellitus, atopic dermatitis, splenic haemangiosarcoma, appendicular osteosarcoma, cranial cruciate ligament disease, thoracolumbar intervertebral disc disease and cervical spondylomyelopathy. A survey of veterinarians (n = 61) was conducted to elicit impaired welfare weights for 35 welfare impediments. Paired comparison was the primary method to elicit weights, whereas visual analogue scale and time trade-off approaches rescaled these weights onto the desired scale, from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable). WALYs for the 10 diseases were then estimated using the impaired welfare weights and published epidemiological data on disease impacts. Welfare impediment “amputation: one limb” and “respiratory distress” had the lowest and highest impaired welfare weights at 0.134 and 0.796, rescaled with a visual analogue scale, and 0.117 and 0.857, rescaled with time trade-off. Among the 10 diseases, thoracolumbar intervertebral disc disease and atopic dermatitis had the smallest and greatest adverse impact on dogs with WALYs at 2.83 (95% UI: 1.54–3.94) and 9.73 (95% uncertainty interval [UI]: 7.17–11.8), respectively. This study developed the WALY metric and demonstrated that it summarises welfare compromise as perceived by humans and total impact of diseases in individual animals. The WALY can potentially be used for prioritisation of disease eradication and control programs, quantification of population welfare and longitudinal surveillance of animal welfare in companion animals and may possibly be extended to production animals.

show abstract

Section: Introductionmentioning

confidence: 99%

Welfare-Adjusted Life Years (WALY): A novel metric of animal welfare that combines the impacts of impaired welfare and abbreviated lifespan

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Eleven of the 52 publications (21%; Table 5 ) described the initial process of validating an instrument. One instrument ( Schneider et al., 2010 ) was intended for generic QoL assessment. Eight instruments were validated for use in specific disease types; the other two instruments ( Mullan, Main, 2007 , Yeates et al, 2011 ) were designed to raise awareness of welfare considerations.…”

Section: Resultsmentioning

confidence: 99%

“…Instruments varied in length from the short instrument of Yeates et al. (2011) to the 88-item questionnaire by Schneider et al. (2010) .…”

Section: Resultsmentioning

confidence: 99%

“…Recall periods were typically short and well defined. Potential sources of bias were acknowledged in four publications ( Budke et al, 2008 , Favrot et al, 2010 , Schneider et al, 2010 , Iliopoulou et al, 2013 ). Based on the results of the Scopus search, while some of the validated instruments had been used by different groups of researchers, most had only appeared in peer-reviewed publications by the authors of the instrument.…”

Section: Resultsmentioning

confidence: 99%

“…Our rapid review found three different applications for validated QoL instruments: (1) QoL assessment in a disease-specific population ( Freeman et al., 2005 ); (2) as an aid to promoting QoL discussions in veterinary practice ( Yeates et al., 2011 ), and (3) as a generic assessment of QoL ( Schneider et al., 2010 ). Eight of the 11 validated instruments included in the review were designed for the first application.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations